US Stock MarketDetailed Quotes
GBCS SELECTIS HEALTH INC
- 1.700
- +0.340+25.00%
15min DelayClose Nov 22 16:00 ET
5.21MMarket Cap-944P/E (TTM)
1.700High1.700Low1.20KVolume1.700Open1.360Pre Close2.04KTurnover0.05%Turnover RatioLossP/E (Static)3.07MShares4.60052wk High-0.93P/B4.13MFloat Cap1.30052wk Low--Dividend TTM2.43MShs Float8.650Historical High--Div YieldTTM0.00%Amplitude1.000Historical Low1.700Avg Price1Lot Size
SELECTIS HEALTH INC Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -152.06%-1.23M | -524.46%-422.92K | 472.41%249.5K | 275.87%536.67K | -636.68%-1.85M | 413.57%2.36M | -92.45%99.64K | 94.50%-67K | -12.63%-305.15K | -74.10%345.5K |
| Net income from continuing operations | 28.96%-1.61M | 137.81%794.34K | -125.71%-1.03M | -65.75%-3.97M | -65.73%-3.63M | -54.93%-2.26M | -304.37%-2.1M | 1,660.19%4.03M | -6.89%-2.4M | -23.97%-2.19M |
| Operating gains losses | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 96.47%-40.44K | -100.18%-90 |
| Depreciation and amortization | 4.54%374.12K | -6.68%409.53K | -3.45%423.6K | -7.06%1.67M | -3.03%430.75K | -21.11%357.87K | -1.90%438.85K | -2.00%438.73K | 3.43%1.79M | -0.64%444.2K |
| Other non cash items | -92.69%3.77K | -91.89%16K | 79.93%79.89K | 10.06%347.78K | --54.46K | --51.64K | --197.29K | --44.4K | 100.89%315.98K | ---- |
| Change In working capital | -121.38%-842.85K | -66.07%369.63K | 113.61%680.22K | 82.11%-240.12K | -122.80%-272.83K | 157,512.08%3.94M | 351.09%1.09M | -137.17%-5M | -535.01%-1.34M | -31.03%1.2M |
| -Change in receivables | -110.96%-560.79K | -918.56%-462.29K | 102.46%165.52K | 13.17%-662K | 310.88%887.06K | 176.35%5.11M | 104.42%56.48K | -634.07%-6.72M | 69.17%-762.38K | -770.63%-420.65K |
| -Change in prepaid assets | -111.54%-41.34K | 24.97%394.02K | 100.87%275.79K | -285.20%-1.98M | -751.94%-2.79M | 91.41%358.16K | -7.31%315.3K | 20.91%137.3K | 59.45%1.07M | 325.14%427.99K |
| -Change in payables and accrued expense | 84.28%-240.73K | -38.97%437.9K | -84.92%238.91K | 245.67%2.4M | 37.07%1.63M | 24.77%-1.53M | 42.63%717.54K | 221.38%1.58M | -178.10%-1.65M | -36.14%1.19M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -152.06%-1.23M | -524.46%-422.92K | 472.41%249.5K | 275.87%536.67K | -636.68%-1.85M | 413.57%2.36M | -92.45%99.64K | 94.50%-67K | -12.63%-305.15K | -74.10%345.5K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -95.66%635 | 2.57M | -174.32%-116.63K | 86.60%-29.81K | -101.77%-1.91K | 106.10%14.62K | 0 | 33.77%-42.52K | 57.20%-222.36K | 518.79%108.41K |
| Capital expenditure reported | -95.66%635 | --89.77K | -174.32%-116.63K | ---- | ---- | 106.10%14.62K | --0 | 33.77%-42.52K | ---- | ---- |
| Net PPE purchase and sale | --0 | ---- | ---- | 86.60%-29.81K | ---29.81K | --0 | ---- | ---- | 57.20%-222.36K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -95.66%635 | --2.57M | -174.32%-116.63K | 86.60%-29.81K | -101.77%-1.91K | 106.10%14.62K | --0 | 33.77%-42.52K | 57.20%-222.36K | 518.79%108.41K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2.99%-973.7K | 73.01%-161.18K | -277.05%-404.75K | 66.54%-618.74K | 236.62%1.09M | -642.99%-1M | 1.96%-597.16K | 65.07%-107.35K | -215.18%-1.85M | -519.61%-797.47K |
| Net issuance payments of debt | 10.51%-973.7K | 73.01%-161.18K | -302.95%-404.75K | 62.71%-695.57K | 237.99%1.09M | -866.39%-1.09M | 1.96%-597.16K | 71.61%-100.45K | -283.73%-1.87M | -731.08%-789.97K |
| Cash dividends paid | --0 | --0 | --0 | 77.00%-6.9K | --0 | --0 | --0 | ---6.9K | 0.00%-30K | ---7.5K |
| Net other financing activities | ---- | ---- | ---- | 80.19%83.73K | ---624 | ---- | ---- | ---- | 149.62%46.47K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2.99%-973.7K | 73.01%-161.18K | -277.05%-404.75K | 66.54%-618.74K | 236.62%1.09M | -642.99%-1M | 1.96%-597.16K | 65.07%-107.35K | -215.18%-1.85M | -519.61%-797.47K |
| Net cash flow | ||||||||||
| Beginning cash position | 136.36%4.02M | -7.59%2.03M | -4.63%2.3M | -49.58%2.42M | 11.28%3.07M | -56.21%1.7M | -31.34%2.2M | -49.58%2.42M | 20.48%4.79M | -23.62%2.76M |
| Current changes in cash | -260.74%-2.2M | 500.08%1.99M | -25.37%-271.88K | 95.29%-111.88K | -123.15%-766.66K | 221.50%1.37M | -172.85%-497.52K | 86.35%-216.86K | -391.67%-2.38M | -129.13%-343.56K |
| End cash Position | -40.66%1.82M | 136.36%4.02M | -7.59%2.03M | -4.63%2.3M | -4.63%2.3M | 11.28%3.07M | -56.21%1.7M | -31.34%2.2M | -49.58%2.42M | -49.58%2.42M |
| Free cash flow | -151.71%-1.23M | -434.36%-333.15K | 221.33%132.87K | 196.09%506.86K | -508.92%-1.86M | 339.26%2.37M | -92.29%99.64K | 91.46%-109.51K | 33.27%-527.51K | -65.30%453.91K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
